✦ LIBER ✦

Upshaw-Schulman Syndrome Revisited: A Concept of Congenital Thrombotic Thrombocytopenic Purpura

✍ Scribed by S. Kinoshita; A. Yoshioka; Y. D. Park; H. Ishizashi; M. Konno; M. Funato; T. Matsui; K. Titani; H. Yagi; M. Matsumoto; Y. Fujimura

Publisher: Carden Jennings Publishing
Year: 2001
Tongue: English
Weight: 180 KB
Volume: 74
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf02982558

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Four patients with both thrombotic throm

Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: The concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange

✍ Beverly W. Baron; Marisa Saint Martin; Brian S. Sucharetza; Hye-Ran Jeon; Joseph 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract Autoimmune thrombocytopenic purpura (ATP) and thrombotic thrombocytopenic purpura (TTP) are each well recognized clinical syndromes which may appear as single episodes or may have chronic relapsing courses. We present four patients negative for human immunodeficiency virus (HIV) infecti

Thrombotic thrombocytopenic purpura/hemo

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange

✍ A. Pereira; R. Mazzara; J. Monteagudo; C. Sanz; L. Puig; A. Martínez; A. Ordinas 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 578 KB

Dissociation between the level of von Wi

Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura

✍ Carolyn E. Snider; Jane C. Moore; Theodore E. Warkentin; Clara N. Finch; Catheri 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract Decreased von Willebrand factor (VWF)‐cleaving protease activity (<5%) has been implicated in patients with congenital thrombotic thrombocytopenic purpura–hemolytic uremic syndrome (Upshaw‐Schulman syndrome) and associated with mutations within the __ADAMTS13__ gene. In this report, we

Thrombotic thrombocytopenic purpura/hemo

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases

✍ J. Dervenoulas; P. Tsirigotis; G. Bollas; V. Pappa; N. Xiros; T. Economopoulos; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 167 KB

Plasma exchange and vincristine in the t

Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation

✍ Victor A. Silva; Debra Frei-Lahr; Randy A. Brown; Geoffrey P. Herzig 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

Hemolytic uremic syndrome/thrombotic thrornbocytopenic purpura (HUSITTP) is a rare and often fatal complication of bonc marrow transplantation (BMT). In this study. wc rcport eight such cases (seven allo and onc auto) treated with plasma exchanges (PE), vincristine (six paticnts), and discontinuatio

A support group for patients who have re

A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group

✍ Mark A. Howard; Deanna Duvall; Deirdra R. Terrell; Anne T. Christopher; Ira Thom 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract A support group for patients who have recovered from thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome (TTP‐HUS), named The Oklahoma TTP‐HUS Study Group, has been a successful program for 6 years. This group has met 3 times each year with an average attendance of 16 former p